Core Biopsy + Questionnaire Administration + AFIMOXIFENE for carcinoma, intraductal, noninfiltrating

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 5 Jul 2019: Trial registered, NCT04009044
  2. 17 Feb 2020: Trial started, NCT04009044

The trials

NCT04009044: Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast

State
Under way
Phase
Phase 2
People
156 planned
Started
17 Feb 2020
Primary completion
31 Jan 2026
Arms
Treatment (afimoxifene)
Results
None posted
  1. 5 Jul 2019: Trial registered
  2. 17 Feb 2020: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.